Bicara Therapeutics Stock
Bicara Therapeutics is developing a pipeline of bifunctional antibodies that exploit the recent advances in immuno-oncology.
Sign up today and learn more about Bicara Therapeutics Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Bicara Therapeutics Stock
President & Chief Operating Officer
Chief Executive Officer
Senior Scientific Advisor
Seng-Lai "Thomas" Tan